Discover the major causes of partial paralysis from stroke and trauma to inflammatory conditions and tumors, plus warning ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

Learn 12 critical neurological warning signs that demand emergency care. Recognize dangerous combinations of dizziness, ...

Romberg test was not performed before the intervention due to trunk instability; after treatment participants presented minimal balance changes ... peripheral nerves are relatively scarce, given that ...

Virus’ strategy to maintain persistent infection discovered in Ohio State studyA study by virologists from the Department of ...

In GBS, tanruprubart is designed to seek out C1q and prevent its binding to targets on peripheral nerves. Tanruprubart is administered intravenously and has been observed to act almost immediately ...

at the 2025 Peripheral Nerve Society (PNS) Annual Meeting being held May 17-20, 2025 in Edinburgh, UK. GBS is a neuromuscular emergency and rare autoimmune disease that affects at least 150,000 ...

Annexon's lead investigational therapy, tanruprubart, is a first-of-its kind selective, targeted and rapid-acting agent designed to reduce inflammation and nerve damage by stopping C1q activity in the ...

In GBS, tanruprubart is designed to seek out C1q and prevent its binding to targets on peripheral nerves. Tanruprubart is administered intravenously and has been observed to act almost immediately ...

In this guide, explore peripheral neuropathy in detail—from its causes and types to key symptoms and more. Learn everything ...